- Home
- BOF vs ENVB Comparison
BOF vs ENVB Comparison
Compare BOF & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- ENVB
- Stock Information
- Founded
- BOF 2017
- ENVB 1994
- Country
- BOF United States
- ENVB United States
- Employees
- BOF N/A
- ENVB N/A
- Industry
- BOF Packaged Foods
- ENVB Biotechnology: Pharmaceutical Preparations
- Sector
- BOF Consumer Staples
- ENVB Health Care
- Exchange
- BOF Nasdaq
- ENVB Nasdaq
- Market Cap
- BOF 15.1M
- ENVB 4.1M
- IPO Year
- BOF 2023
- ENVB N/A
- Fundamental
- Price
- BOF $1.80
- ENVB $0.37
- Analyst Decision
- BOF
- ENVB Strong Buy
- Analyst Count
- BOF 0
- ENVB 1
- Target Price
- BOF N/A
- ENVB $10.00
- AVG Volume (30 Days)
- BOF 121.1K
- ENVB 559.4K
- Earning Date
- BOF 11-14-2024
- ENVB 11-14-2024
- Dividend Yield
- BOF N/A
- ENVB N/A
- EPS Growth
- BOF N/A
- ENVB N/A
- EPS
- BOF N/A
- ENVB N/A
- Revenue
- BOF $6,489,951.00
- ENVB N/A
- Revenue This Year
- BOF N/A
- ENVB N/A
- Revenue Next Year
- BOF N/A
- ENVB N/A
- P/E Ratio
- BOF N/A
- ENVB N/A
- Revenue Growth
- BOF 372.36
- ENVB N/A
- 52 Week Low
- BOF $0.61
- ENVB $0.30
- 52 Week High
- BOF $4.11
- ENVB $2.92
- Technical
- Relative Strength Index (RSI)
- BOF 52.41
- ENVB 49.64
- Support Level
- BOF $1.53
- ENVB $0.35
- Resistance Level
- BOF $2.08
- ENVB $0.39
- Average True Range (ATR)
- BOF 0.16
- ENVB 0.05
- MACD
- BOF -0.00
- ENVB 0.00
- Stochastic Oscillator
- BOF 49.09
- ENVB 32.51
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.